Harmony Biosciences Holdings Stock In The News
| HRMY Stock | USD 29.23 0.38 1.32% |
The overall news coverage of Harmony Biosciences Holdings from major news outlets shows solid bullish sentiment on 12 news articles, blog posts, and TV commentaries analyzed in the last few months. Our overall analysis of Harmony Biosciences' news coverage and content from conventional and social sources shows investors' bearish mood towards Harmony Biosciences Holdings. The specific impact of Harmony Biosciences news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of Harmony Biosciences' overall financial health and prospects. It also depends on the type and quality of a news publisher.
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Harmony Biosciences headlines in addition to utilizing other, more conventional financial analysis modules. Check out Harmony Biosciences Backtesting and Harmony Biosciences Hype Analysis.
Harmony |
Harmony Biosciences Today Top News and Investor Outlook
Harmony Biosciences Holdings Past News Timeline
Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide Harmony and other traded companies coverage. We help investors stay connected with Harmony headlines for the 24th of April to make an informed investment decision based on correlating the impacts of news items on Harmony Stock performance. Please note that trading solely based on the Harmony Biosciences Holdings hype is not for everyone as timely availability and quick action are needed to avoid losses.Harmony Biosciences stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the Harmony earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about Harmony Biosciences that are available to investors today. That information is available publicly through Harmony media outlets and privately through word of mouth or via Harmony internal channels. However, regardless of the origin, that massive amount of Harmony data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Harmony Biosciences news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Harmony Biosciences relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Harmony Biosciences' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Harmony Biosciences alpha.
Harmony Largest EPS Surprises
Earnings surprises can significantly impact Harmony Biosciences' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2022-08-02 | 2022-06-30 | 0.44 | 0.39 | -0.05 | 11 | ||
2021-08-10 | 2021-06-30 | 0.18 | 0.24 | 0.06 | 33 | ||
2023-08-01 | 2023-06-30 | 0.63 | 0.56 | -0.07 | 11 | ||
2020-11-12 | 2020-09-30 | -0.05 | -0.14 | -0.09 | 180 | ||
2023-10-31 | 2023-09-30 | 0.65 | 0.75 | 0.1 | 15 | ||
2021-03-25 | 2020-12-31 | 0.09 | 0.25 | 0.16 | 177 |
Harmony Biosciences Stock Latest Headlines
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to Harmony Biosciences Stock. The global stock market is bearish. About 60% of major world exchanges and indexes are down. See today's market update for more information.
12th of April 2024
HARMONY BIOSCIENCES ANNOUNCES EXCLUSIVE AGREEMENT TO DEVELOP AND COMMERCIALIZE TPM ... - M... at news.google.com
11th of April 2024
Harmony stock gains on deal for narcolepsy drug at seekingalpha.com
3rd of April 2024
HARMONY BIOSCIENCES INITIATES GLOBAL PHASE 3 REGISTRATIONAL TRIAL OF PITOLISANT IN PATIENT... at finance.yahoo.com
26th of March 2024
HARMONY BIOSCIENCES TO PARTICIPATE IN 23RD ANNUAL NEEDHAM VIRTUAL HEALTHCARE CONFERENCE at investing.com
19th of March 2024
Insider Activity Update Jeffrey Dierks Executes Options Exercise, Resulting In 279K At Har... at benzinga.com
14th of March 2024
Harmony Biosciences Stock Price Up 4.1 percent - MarketBeat at news.google.com
11th of March 2024
Advisors Asset Management Inc. Cuts Stake in Harmony Biosciences Holdings, Inc. - Defense ... at news.google.com
23rd of February 2024
Harmony Biosciences Holdings, Inc. Q4 2023 Earnings Call Transcript at insidermonkey.com
Harmony Biosciences Investors Sentiment
The influence of Harmony Biosciences' investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Harmony. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Harmony Biosciences' public news can be used to forecast risks associated with an investment in Harmony. The trend in average sentiment can be used to explain how an investor holding Harmony can time the market purely based on public headlines and social activities around Harmony Biosciences Holdings. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Harmony Biosciences' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Harmony Biosciences' and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Harmony Biosciences' news discussions. The higher the estimated score, the more favorable is the investor's outlook on Harmony Biosciences.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Harmony Biosciences in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Harmony Biosciences' short interest history, or implied volatility extrapolated from Harmony Biosciences options trading.
Check out Harmony Biosciences Backtesting and Harmony Biosciences Hype Analysis. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Complementary Tools for Harmony Stock analysis
When running Harmony Biosciences' price analysis, check to measure Harmony Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Harmony Biosciences is operating at the current time. Most of Harmony Biosciences' value examination focuses on studying past and present price action to predict the probability of Harmony Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Harmony Biosciences' price. Additionally, you may evaluate how the addition of Harmony Biosciences to your portfolios can decrease your overall portfolio volatility.
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| AI Investment Finder Use AI to screen and filter profitable investment opportunities |
Is Harmony Biosciences' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Harmony Biosciences. If investors know Harmony will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Harmony Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.43) | Earnings Share 2.13 | Revenue Per Share 9.787 | Quarterly Revenue Growth 0.313 | Return On Assets 0.1616 |
The market value of Harmony Biosciences is measured differently than its book value, which is the value of Harmony that is recorded on the company's balance sheet. Investors also form their own opinion of Harmony Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Harmony Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Harmony Biosciences' market value can be influenced by many factors that don't directly affect Harmony Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Harmony Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Harmony Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Harmony Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.